Given the involvement of pyroptosis in psoriasis, which shares many inflammatory pathways with HS, it is reasonable to hypothesize that targeting the gasdermin-mediated pyroptosis pathway could offer therapeutic potential in HS. The gene discussed is GSDMA; the disease is histiocytic sarcoma.